만성질환 유병상태 및 건강검진 결과와 주관적 건강인식의 관련성 연구

학위논문(석사)--서울대학교 보건대학원 :보건학과, 보건정책관리학전공,2006.Maste

제약산업 구조분석과 발전방향(Structure analysis and improving strategies on pharmaceutical industry)

노트 : In 2010, the pharmaceutical industry accounted for 1.43% of Korea’s GDP, with a considerable influence on the national economy. So, the government has enacted laws and reorganized institutions to foster the pharmaceutical industry as a global pharmaceutical conglomerate. Nevertheless, the Korean pharmaceutical companies still remain small. These companies are overly profit-oriented, focusing on sales rather than R&D. Their business structure has been often criticized as inimical to the competitiveness of the Korean pharmaceutical industry. In addition, as the national health spending has continuously increased due to population ageing, reducing pharmaceutical spending accounting for 30% of health insurance reimbursement will have a great effect on the future of the pharmaceutical industry. This study analyzes the changing environment of the pharmaceutical industry and the structural characteristics of the Korean pharmaceutical industry from various perspectives, and draws measures to improve its structures and to gain it competitive edge based on the analysis